Hepatitis C News and Research

Latest Hepatitis C News and Research

Antiviral therapy cuts progression to cancer in hepatitis

Antiviral therapy may prevent the most common form of liver cancer developing among patients who have hepatitis C-related fibrosis or cirrhosis, report researchers.

25 Oct 2012

Rapid and point-of-care tests accurate, convenient for hepatitis C screening

Rapid and point-of-care screening tests for hepatitis C have a high accuracy and quick turnaround time, suggest results of a systematic review and meta-analysis.

24 Oct 2012

Primary care physicians miss hepatitis vaccine targets

Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.

22 Oct 2012

BioLineRx completes pre-clinical development of BL-8020 for HCV

BioLineRx, a biopharmaceutical development company, announced today that it has successfully completed the pre-clinical development of BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus (HCV), and plans to commence a Phase I/II safety and efficacy study for BL-8020 in Europe during the first quarter of 2013.

17 Oct 2012

Hepatitis C rapid and point of care tests highly accurate and reliable

Timely screening and diagnosis is critical to the success of new treatments and ultimately to the survival of hepatitis C patients. A new study led by the Research Institute of the McGill University Health Centre (RI MUHC) is the first to show that hepatitis C rapid and point of care tests with a quick turnaround time are highly accurate and reliable as conventional first-line laboratory tests.

16 Oct 2012

Statins could be first preventive treatment for liver cancer

Statins may reduce the risk for hepatocellular carcinoma, show the results of a meta-analysis.

15 Oct 2012

AAPS recognizes top scientists in pharmaceutical sciences

During the Opening Session of the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, AAPS President David Y. Mitchell, Ph.D., presented the following ground-breaking researchers with awards commemorating their contributions to the pharmaceutical sciences:

15 Oct 2012

Indonesia issues order to override patents on 7 HIV, hepatitis drugs

"Indonesia's government has quietly issued an order to override the patents on seven important medicines used to treat people with HIV and hepatitis B and allow cheap versions to be made by local drug companies," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."

15 Oct 2012

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Working with individuals with traumatic brain injury (TBI) every day, I see the debilitating effects and long-term struggles firsthand.

9 Oct 2012

Treatment of hepatitis C can be successful in a prison population

Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.

8 Oct 2012

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.

8 Oct 2012

Incidence of needlestick injuries appears to be lower among employees at retail pharmacy chain

Vaccinations for flu, tetanus and other common vaccines are increasingly taking place in non-medical settings such as supermarkets and drug stores. This added responsibility for pharmacists increases the risk of needlestick injuries (NSIs), puncture wounds often suffered while preparing or after use of a needle. NSIs can transmit bloodborne pathogens, including hepatitis C and HIV, from an infected patient to the person administering the vaccine.

8 Oct 2012

Nursing intervention can significantly decrease substance abuse among homeless youth

A new study led by researchers from the UCLA School of Nursing has found that nursing intervention can significantly decrease substance abuse among homeless youth.

4 Oct 2012

Roche announces availability of new HIV-1 viral load test in the U.S.

Roche announced today the U.S. availability of a new HIV-1 viral load test based on the company's proprietary dual-target approach. The COBAS TaqMan HIV-1 Test v2.0 for use with the High Pure System enables labs to combine an FDA-approved process for manual specimen preparation with an automated real-time PCR analyzer for amplification and detection.

From Roche Sequencing and Life Science 4 Oct 2012

Human hepatitis threat present in domestic pigs

The prevalence of hepatitis E virus in domestic pigs is between 10% and 30%, with a likelihood that infected pigs enter the pork production chain thereby threatening public health, indicate Portuguese study results.

2 Oct 2012

News outlets examine challenges to fighting polio in Pakistan, Nigeria

In Pakistan, one of only three nations worldwide where polio remains endemic, "rumors and conspiracy theories about the vaccine ... have helped the country maintain its unenviable status," recording 91 cases of the disease in 2011, Agence France-Presse reports.

2 Oct 2012

Roundup: Calif. bans gay 'cure' for minors; Pittsburgh health system merger falls apart; Ariz. seeks federal approval to continue Medicaid program

California has become the first state to ban the use for minors of disputed therapies to "overcome" homosexuality, a step hailed by gay rights groups across the country that say the therapies have caused dangerous emotional harm to gay and lesbian teenagers.

2 Oct 2012

New studies reveal real economic and human costs of caring for cancer patients in Europe

New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe will be presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

29 Sep 2012

EC approves Janssen’s DACOGEN for treatment of de novo acute myeloid leukaemia

Janssen-Cilag International NV announced today that the European Commission has approved the marketing authorisation for DACOGEN(decitabine) for the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukaemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy.

28 Sep 2012

Thymus tissue, iPSCS and liver cells can thrive in lymph nodes

Lymph nodes can provide a suitable home for a variety of cells and tissues from other organs, suggesting that a cell-based alternative to whole organ transplantation might one day be feasible, according to researchers at the University of Pittsburgh School of Medicine and its McGowan Institute for Regenerative Medicine.

28 Sep 2012

Hepatitis C News and Research

Latest Hepatitis C News and Research

Antiviral therapy cuts progression to cancer in hepatitis

Rapid and point-of-care tests accurate, convenient for hepatitis C screening

Primary care physicians miss hepatitis vaccine targets

BioLineRx completes pre-clinical development of BL-8020 for HCV

Hepatitis C rapid and point of care tests highly accurate and reliable

Statins could be first preventive treatment for liver cancer

AAPS recognizes top scientists in pharmaceutical sciences

Indonesia issues order to override patents on 7 HIV, hepatitis drugs

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Treatment of hepatitis C can be successful in a prison population

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Incidence of needlestick injuries appears to be lower among employees at retail pharmacy chain

Nursing intervention can significantly decrease substance abuse among homeless youth

Roche announces availability of new HIV-1 viral load test in the U.S.

Human hepatitis threat present in domestic pigs

News outlets examine challenges to fighting polio in Pakistan, Nigeria

Roundup: Calif. bans gay 'cure' for minors; Pittsburgh health system merger falls apart; Ariz. seeks federal approval to continue Medicaid program

New studies reveal real economic and human costs of caring for cancer patients in Europe

EC approves Janssen’s DACOGEN for treatment of de novo acute myeloid leukaemia

Thymus tissue, iPSCS and liver cells can thrive in lymph nodes

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Hepatitis C News and Research

Latest Hepatitis C News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in